Abstract

Common variable immunodeficiency (CVID) is the most common clinically severe primary immunodeficiency and comprises a heterogeneous group of patients with recurrent severe bacterial infections due to the failure to produce IgG antibodies after exposure to infectious agents and immunization. Diagnostic recommendations for antibody failure include assessment of isoagglutinins. We have readdressed this four decades old but still accepted recommendation with up to date methodology. Anti-A/B IgM- and IgG-antibodies were measured by Diamed-ID Micro Typing, surface plasmon resonance (SPR) using the Biacore(®) device and flow cytometry. When Diamed-ID Micro Typing was used, CVID patients (n = 34) showed IgG- and IgM-isoagglutinins that were comparable to healthy volunteers (n = 28), while all XLA patients (n = 8) had none. Anti-A/B IgM-antibodies were present in more than 2/3 of the CVID patients and showed binding kinetics comparable to anti-A/B IgM-antibodies from healthy individuals. A correlation could be found in CVID patients between levels of anti-A/B IgM-antibodies and levels of serum IgM and PnP-IgM-antibodies. In contrast in CVID patients as a group ABO antibodies were significantly decreased when assessed by SPR, which correlated with levels of switched memory, non-switched memory and naïve B cells, but all CVID patients had low/undetectable anti-A/B IgG-antibodies. These results indicate that conventional isoagglutinin assessment and assessment of anti-A/B IgM antibodies are not suited for the diagnosis of impaired antibody production in CVID. Examination of anti-A/B IgG antibodies by SPR provides a useful method for the diagnosis of IgG antibody failure in all CVID patients studied, thus indicating an important additional rationale to start immunoglobulin replacement therapy early in these patients, before post-infectious sequelae develop.

Highlights

  • Materials and MethodsCommon variable immunodeficiency (CVID) is a heterogeneous disorder belonging to the group of primary antibody deficiencies, characterized by markedly reduced serum levels of IgG, IgA, and often IgM, and a substantial failure to produce specific IgG antibodies after vaccination or exposure to foreign antigens [1,2,3,4,5]

  • Blood Group Anti-A/B Antibodies did not Differ Between CVID Patients and Healthy Individuals When Determined by Diamed-ID Micro Typing When the amount of anti-blood group A (anti-A)/B antibodies in samples of 34 CVID patients, diagnosed according to the criteria established by the IUIS expert committee [5], was determined by the Diamed-ID Micro Typing System using the ID-Card 50520 (NaCl) to measure IgM-isoagglutinins, no difference could be found between CVID patients and healthy individuals (Figure 1A, left panel)

  • IgG- in addition to IgM-isoagglutinins, the isoagglutinin titers detected were higher as compared to the NaCl-system, but still no difference was observed between CVID patients and controls (Figure 1A, right panel)

Read more

Summary

Introduction

Common variable immunodeficiency (CVID) is a heterogeneous disorder belonging to the group of primary antibody deficiencies, characterized by markedly reduced serum levels of IgG, IgA, and often IgM, and a substantial failure to produce specific IgG antibodies after vaccination or exposure to foreign antigens [1,2,3,4,5]. This renders patients susceptible to recurrent sinopulmonary, ear, and gastrointestinal infections, the underlying regulatory immune defect can lead to autoimmune diseases, and certain malignancies may occur more frequently. We have readdressed this four decades old but still accepted recommendation with up to date methodology

Objectives
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call